← SynDRA
ZURANOLONE
SynDRA canonical compound SYN0039290 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | GABRA1 | GABRA4 |
|---|
| Mechanism of action | GABA receptor agonist |
|---|
All known targets
- GABRA1
- GABRA4
- GABRB2
- GABRB3
- GABRD
- GABRG2
- GABRG3
Mechanisms of action (all sources)
- GABA receptor agonist
- GABRG3 MODULATOR
- GABRA1 ALLOSTERIC MODULATOR
- GABRG2 ALLOSTERIC MODULATOR
- GABRB2 ALLOSTERIC MODULATOR
- GABRA4 ALLOSTERIC MODULATOR
- GABRB3 ALLOSTERIC MODULATOR
- GABRD ALLOSTERIC MODULATOR
Drug classes
ATC classes
Cross-references
Synonyms
- SAGE-217
- SGE-797
- S-812217
- zurzuvae
- Zurzuvae
- HARRKNSQXBRBGZ-GVKWWOCJSA-N
- SCHEMBL16189866
- HY-103040
- CS-0023489
- 7ZW49N180B
- SAGE 217
- SGE 797
- zuranolonum
- RefChem:57736
- DTXCID401559999
- Zuranolone [INN]
- Zuranolone [USAN]
- ZuranoloneSAGE-217
- SAGE217
- Zurzuvae (TN)
- MFCD31619241
- Zuranolone [WHO-DD]
- Zuranolone [USAN:INN]
- BIIB125
- Zuranolone (SAGE-217)?
- UNII-7ZW49N180B
- Zuranolone (JAN/USAN/INN)
- BIIB-125
- orb1818838
- GTPL12858
- CHEBI:228302
- DEA NO. 2420
- GLXC-15028
- EX-A1880
- HQC05140
- BDBM50258216
- WHO 10896
- AKOS037648887
Look up ZURANOLONE in the interactive SynDRA portal →